Author Archive: AZBio

BD Names Bridget Bagnato Worldwide President of Peripheral Intervention

Posted on by

FRANKLIN LAKES, N.J., Nov. 4, 2026 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Bridget Bagnato has been appointed worldwide president of its Peripheral Intervention business unit, effective November 16.

Based at Peripheral Intervention’s headquarters in Tempe, Arizona, Bagnato will be responsible for driving the business unit’s global strategic, operational and commercial performance. She will report to Peter Menziuso, executive vice president and president of the Interventional segment.Continue reading→

Arizona Bioscience on the Rise: Highlights from the 2026 TEConomy/BIO Report

Posted on by

Arizona’s bioscience industry isn’t just growing. It’s outpacing the nation.

The 2026 edition of The U.S. Bioscience Economy from TEConomy Partners and the Biotechnology Innovation Organization (BIO) gives us a fresh look at how Arizona stacks up. The short version: since 2021, our bioscience workforce has grown 13.4 percent, nearly twice the national rate of 7.0 percent. Here’s what’s driving that momentum.Continue reading→

BD Advances Portal Hypertension Care in the U.S. with Support for More Personalized Treatment Options

Posted on by

Oct. 28, 2026 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. commercial launch of the BD® Liverty™ TIPS Stent Graft, advancing portal hypertension care by giving physicians greater flexibility to tailor treatment to each patient’s hemodynamic needs. The next generation transjugular intrahepatic portosystemic shunt (TIPS) system is designed to provide physicians with deployment accuracy and control, and the flexibility to tailor treatment based on individual patient anatomy, disease progression and clinical goals. The product enters the U.S. market with established clinical and physician experience in Europe and is supported by the six-month interim results from the 177 patient, prospective, multi-center ARCH clinical study, the first and only IDE study with small TIPS diameter (6-7 mm) clinical data.Continue reading→

Treasury Issues Proposed Rule to Implement Comprehensive Outbound Investment National Security Act

Posted on by

WASHINGTON– The U.S. Department of the Treasury (Treasury) today issued a Notice of Proposed Rulemaking (NPRM) to propose updates to the Outbound Investment Security Program (OISP) based on direction from Congress in the Comprehensive Outbound Investment Security (COINS) Act, passed as part of the Fiscal Year 2026 National Defense Authorization Act.  The COINS Act codifies the U.S. Government’s approach to regulating certain outbound investments by U.S. persons and builds upon Treasury’s existing OISP. 

Continue reading→